Ian A. Pringle - Concepedia

Author

Ian A. Pringle

University of Oxford

Also Known As

I A Pringle, I Pringle, I. A. Pringle, I. Pringle, Ian A Pringle, Ian A. Pringle, Ian PRINGLE, Ian Pringle, Pringle, IA

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Oxford John Radcliffe Hospital Cystic Fibrosis Trust Imperial College London University of Edinburgh

About

Ian A. Pringle is an author at University of Oxford specializing in medicine, gene transfer, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	529
2	Natural Sciences	4	4	118
3	Allergy	3	3	96
4	Engineering	1	1	15
5	Biomolecular Engineering	1	1	45

Ian A. Pringle

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial Eric W.F.W. Alton, David K Armstrong, Deborah Ashby, The Lancet Respiratory Medicine	2015	417
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis Eric W.F.W. Alton, Jeffrey M. Beekman, A. Christopher Boyd, Thorax Translational MedicineLung Gene TransferViral DiagnosticsViral PathogenesisPharmacology	2016	141
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung Gerry McLachlan, H Davidson, Emma Holder, Gene Therapy Aerosol DeliveryImmunologyRespiratory InfectionInfectious Respiratory DiseasePulmonary Fibrosis	2011	101
The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes Lee A. Davies, Stephen C. Hyde, G. Nunez-Alonso, Biomaterials Aerosol DeliveryCpg-free PlasmidsNatural SciencesMolecular BiologyPersistent Gene Expression	2012	45
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis Eric W.F.W. Alton, David K Armstrong, Deborah Ashby, Efficacy and Mechanism Evaluation Secondary Clinical OutcomesInflammatory Lung DiseaseIn Vivo Gene TherapyLung InflammationAdvanced Lung Disease	2016	45
Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung Ian A. Pringle, Gerry McLachlan, David Collie, The Journal of Gene Medicine	2007	42
Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear Import Felix M. Munkonge, Vaksha Amin, Stephen C. Hyde, Journal of Biological Chemistry	2009	41
Detection of plasmid DNA vectors following gene transfer to the murine airways Ian A. Pringle, S Raman, W W Sharp, Gene Therapy Gene TherapiesPlasmid Dna VectorsMolecular Biological MethodMedicineGenetics	2005	41
Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung Eric W.F.W. Alton, Alan Boyd, Shuk Han Cheng, Gene Therapy Lipid PreparationAllergyRespiratory ToxicologyMedicineRepeated Administration	2013	38
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis Kenneth L. Clark, Stephen Hughes, Pallav A. Bulsara, Molecular Therapy — Nucleic Acids	2013	35

Page 1